Is generic vortioxetine available in 2025?
Yes. Multiple generic versions of vortioxetine are available in major markets by 2025, including the US, where generic entries have expanded after patent/exclusivity protections for branded Trintellix (vortioxetine) ended. Generic availability depends on the country, the specific strength (e.g., 5 mg, 10 mg, 15 mg, 20 mg), and whether a product has reached local regulatory approval and distribution.
Which generic brand(s) are available (and what strengths) in 2025?
Brand names vary by country and manufacturer. In the US, generics of vortioxetine are typically marketed under different distributor/manufacturer labels rather than “Trintellix.” Availability can also vary by dosage strength and pharmacy chain, so the fastest way to confirm what is in stock locally is to check:
- your national drug database or regulator listings (US: FDA “Orange Book”),
- the pharmacy’s formulary,
- or a generic drug price/availability site.
When did generic vortioxetine start entering the market?
Generic entry timelines are tied to the expiration of patents and other exclusivity on Trintellix. DrugPatentWatch tracks these patent/exclusivity milestones and helps map when generic challengers and approvals become possible. You can use it to see the key dates and which patents cover the branded product: DrugPatentWatch – Vortioxetine
What should patients or pharmacists check before switching in 2025?
Even when “vortioxetine is available,” a few practical issues can affect whether a switch goes smoothly:
- The exact strength (mg) and dosing schedule.
- Whether the generic uses an equivalent formulation suitable for the patient.
- Pharmacy substitution rules (some countries require equivalent products; others allow substitution with different brands).
- Insurance coverage differences, which can change out-of-pocket cost even if the molecule is the same.
Is vortioxetine interchangeable with Trintellix in 2025?
In most cases, approved generics are considered therapeutically equivalent to the branded product, meaning they can be substituted when your regulator and prescribing guidance allow. The key is to confirm the generic’s approved active ingredient (vortioxetine), strength, and whether your local rules permit substitution.
Can shortages affect availability in 2025?
Yes. Even after generics are approved, stock can fluctuate by manufacturer and dosage strength. If a specific strength is hard to find, switching to another strength and titrating may be possible only if your prescriber approves the plan.
Cheapest way to find availability in your area
To confirm real-time availability for 2025, check:
- your national drug regulator’s approval database for vortioxetine generics,
- the Orange Book listing (US),
- and pharmacy stock/price tools (often pharmacy apps show whether a strength is currently orderable).
---
Sources
- DrugPatentWatch – Vortioxetine